Novo Nordisk
NVO
#78
Rank
S$275.59 B
Marketcap
S$62.02
Share price
-0.27%
Change (1 day)
-56.73%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2025 : S$34.62 Billion

According to Novo Nordisk's latest financial reports the company has S$34.62 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$27.21 B30.56%
2023-12-31$S$20.84 B29.32%
2022-12-31$S$16.11 B10.69%
2021-12-31$S$14.56 B5.15%
2020-12-31$S$13.84 B18.95%
2019-12-31$S$11.64 B7.29%
2018-12-31$S$10.85 B1.02%
2017-12-31$S$10.74 B15.79%
2016-12-31$S$9.27 B-4.72%
2015-12-31$S$9.73 B11.96%
2014-12-31$S$8.69 B-12.91%
2013-12-31$S$9.98 B13.33%
2012-12-31$S$8.81 B4.29%
2011-12-31$S$8.44 B-0.58%
2010-12-31$S$8.49 B-12.07%
2009-12-31$S$9.66 B8.86%
2008-12-31$S$8.87 B-2.17%
2007-12-31$S$9.07 B10.78%
2006-12-31$S$8.19 B12.62%
2005-12-31$S$7.27 B-8.22%
2004-12-31$S$7.92 B9.04%
2003-12-31$S$7.26 B18%
2002-12-31$S$6.15 B6.86%
2001-12-31$S$5.76 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
S$120.64 B 248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$30.90 B-10.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.10 B-30.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$111.83 B 223.03%๐Ÿ‡ซ๐Ÿ‡ท France